##semicolon##
ревматоидный артрит, биомаркеры, Anti-CarP, VEGF.##submission.citations##
1. Almutairi K et al. Epidemiology and classification criteria of rheumatoid arthritis: A review. Cureus.2021;13(1):e12549. https://doi.org/10.7759/cureus.12549
2. Angelotti F et al. Biomarkers and pathogenesis in rheu- matoid arthritis: Role of angiogenesis and hypoxia. 2021; 2021: 6672723. https://doi.org/10.1155/2021/6672723
3. Kim YJ et al. Clinical significance of VEGF as a biomarker in rheumatoid arthritis patients. Diagnostics.2023;13(9):1653. https://doi.org/10.3390/diagnostics13091653
4. Kleyer A, Schett G. Arthritis and bone loss: A clinical review. Bone.2018;117:227-34. https://doi.org/10.1016/j. bone.2018.09.007
5. Li H et al. IL-17A and TNF-α synergy in rheumatoid ar- thritis pathogenesis. Sign Transduct Target Ther.2024;9(1):34. https://doi.org/10.1038/s41392-023-01331-9
6. Navarro-Millἀn I et al. Biomarkers in rheumatoid ar- thritis: A review on the pathogenesis and clinical utility. Curr Rheumatol Rep.2019;21(6):30. https://doi.org/10.1007/ s11926-019-0831-5
7. Shi J et al. Anti-CarP antibodies as predictors of joint damage in rheumatoid arthritis. Rheumatology International, (2023). 43, 801–809. https://doi.org/10.1007/s00296-023- 05251-2
8. Smolen JS et al. Rheumatoid arthritis. Lancet. 2020; 396 (10246): 1681-94. https://doi.org/10.1016/S0140-6736(20)32323-5
9. Watanabe A et al. Predictive value of anti-CarP and ACPA antibodies in early RA: A longitudinal cohort study. BMC Mus- culoskeletal Dis.2022;23(1):527. https://doi.org/10.1186/ s12891-022-05555-w
10. Willemze A et al. The ACPA response in RA: Understanding its importance and diagnostic value. Front Immunol. 2019;10:113. https://doi.org/10.3389/fimmu.2019.01113